 Clever Leaves is a 284m market-cap producer of pharmaceutical-grade cannabinoids that listed on the Nasdaq via a SPAC acquisition in December 2020. The company is developing growing operations in Colombia - where it has 1.8m square foot of cultivation footprint - and Portugal. Both sites have EU-GMP certification. 